Robotic-Assisted Versus Manual Prostatic Arterial Embolization for Benign Prostatic Hyperplasia: A Comparative...

Area of Science:

• Interventional Radiology
• Urology
• Medical Robotics

Background:

• Benign prostatic hyperplasia (BPH) is a common condition requiring effective treatment.
• Prostatic artery embolization (PAE) is a minimally invasive treatment option for BPH.
• PAE can be technically challenging, prompting exploration of advanced techniques.

Purpose of the Study:

• To compare the technical and clinical outcomes of robotic-assisted PAE versus manual PAE for BPH.
• To evaluate factors including success rates, clinical improvement, cost, and radiation dose.

Main Methods:

• Retrospective study of 40 BPH patients undergoing PAE (May 2014 - July 2015).
• 20 patients received robotic-assisted PAE (Magellan Robotic System), 20 received manual PAE.
• Outcomes assessed: American Urological Association Symptom Index (AUA-SI), technical/clinical success, cost, radiation dose, procedure time.

Main Results:

• Technical success rates were high and comparable: 100% robotic vs. 95% manual.
• Both groups showed significant clinical improvement in AUA-SI scores at 3 months.
• Robotic PAE had a higher disposable cost ($4530.2 vs. $1588.5) but similar procedure times and radiation dose.

Conclusions:

• Robotic-assisted PAE provides technical success comparable to manual PAE for BPH treatment.
• Clinical outcomes and symptom improvement are similar between robotic and manual PAE.
• The primary difference lies in the significantly increased cost associated with the robotic approach.